Lanadoxin
Molecular Formula:
C30H44O9
InChI: InChI=1/C30H44O9/c1-16-27(34)22(32)12-25(38-16)39-19-6-8-28(2)18(11-19)4-5-21-20(28)7-9-29(3)26(17-10-24(33)36-14-17)23(37-15-31)13-30(21,29)35/h10,15-16,18-23,25-27,32,34-35H,4-9,11-14H2,1-3H3/t16u,18-,19-,20u,21u,22?,23?,25+,26+,27-,28+,29-,30+/m1/s1
InChIKey: InChIKey=IOXIBFLACIBMNF-PUBGEONOBO
SMILES: CC1C(C(CC(O1)OC2CCC3(C(C2)CCC4C3CCC5(C4(CC(C5C6=CC(=O)OC6)OC=O)O)C)C)O)O
Names:
BRN 0070815
Card-20(22)-enolide, 3-((2,6-dideoxy-beta-D-ribo-hexopyranosyl)oxy)-16-(formyloxy)-14-hydroxy-, (3-beta,5-beta,16-beta)-
CARD-20(22)-ENOLIDE, 3-((2,6-DIDEOXY-beta-D-ribo-HEXOPYRANOSYL)OXY)-16-(FORMYLOX
EINECS 258-734-4
Gitaloxigenin-mono-digitoxosid [German]
Lanadoxin
(3beta,5beta,16beta)-3-((2,6-Dideoxy-beta-D-ribo-hexopyranosyl)oxy)-14,16-dihydroxycard-20(22)-enolide 16-formate
11014-58-7
4-18-00-02466 (Beilstein Handbook Reference)
53735-73-2
[(3R,5R,10S,13R,14S,17S)-3-[(2R,5S)-4,5-dihydroxy-6-methyl-oxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-17-(5-oxo-2H-furan-3-yl)-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-16-yl] formate
Registries:
PubChem CID 11967833
PubChem ID 181661
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|